FDA 483 - Nippon Fine Chemical Co., Ltd. - June 11, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Nippon Fine Chemical Co. Ltd, a drug excipient and active pharmaceutical ingredient manufacturer in Takasago City, Japan, was cited for significant procedural deficiencies during an FDA inspection. Observations included inadequate investigation of out-of-specification results and deviation handling, failure to meet deadlines for annual product quality reviews, and insufficient qualification of major raw material suppliers. These issues indicate a lack of adherence to established quality system procedures.
ID · de5dea24-ded0-4b35-acf8-f3f462ad6df9